SEC Form 4 · accession 0001162194-18-000085
STANDARD BIOTOOLS INC. · LAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicholas Khadder
Officer — See Remarks
Period of report
Jun 11, 2018
Accepted (ET)
Jun 13, 2018 · 8:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001162194
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 11,121 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2,F3 | — | Jun 11, 2018 | A | 36,016 | A | — | — | Common Stock | 36,016 | 36,016 | D |
Explanation of responses
- F1Includes 1,060 shares purchased on May 31, 2018 under the Company's 2017 Employee Stock Purchase Plan.
- F2Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit.
- F33/48th of the total number of shares underlying the Restricted Stock Units granted will vest on August 20, 2018, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to Reporting Person's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through the applicable vest date.
Remarks
Senior Vice President, General Counsel, and Corporate Secretary